Literature DB >> 18690504

Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.

Joke S Kalkman1, Machiel J Zwarts, Maartje L Schillings, Baziel G M van Engelen, Gijs Bleijenberg.   

Abstract

Although fatigue is a common symptom in neuromuscular disorders, little is known about different types of fatigue. Sixty-five FSHD, 79 adult-onset MD and 73 HMSN type I patients were studied. Experienced fatigue was assessed with the CIS-fatigue subscale. Physiological fatigue was measured during a 2-min sustained maximal voluntary contraction of the biceps brachii muscle using the twitch interpolation technique to assess central activation failure (CAF) and peripheral fatigue. Experienced fatigue, CAF and peripheral fatigue appeared to be predominantly separate types of fatigue.

Entities:  

Mesh：

Year:  2008        PMID： 18690504     DOI： 10.1007/s10072-008-0949-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  9 in total

1.  Relative contributions of central and peripheral factors to fatigue during a maximal sustained effort.

Authors:  Maartje L Schillings; Wouter Hoefsloot; Dick F Stegeman; Machiel J Zwarts
Journal:  Eur J Appl Physiol       Date:  2003-08-05       Impact factor: 3.078

2.  Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.

Authors:  J S Kalkman; M L Schillings; M J Zwarts; B G M van Engelen; G Bleijenberg
Journal:  Acta Neurol Scand       Date:  2007-04       Impact factor: 3.209

3.  Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.

Authors:  J S Kalkman; M L Schillings; S P van der Werf; G W Padberg; M J Zwarts; B G M van Engelen; G Bleijenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

4.  Central and peripheral contributions to muscle fatigue in humans during sustained maximal effort.

Authors:  J A Kent-Braun
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1999-06

Review 5.  Spinal and supraspinal factors in human muscle fatigue.

Authors:  S C Gandevia
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

6.  Experienced and physiological fatigue in neuromuscular disorders.

Authors:  M L Schillings; J S Kalkman; H M H A Janssen; B G M van Engelen; G Bleijenberg; M J Zwarts
Journal:  Clin Neurophysiol       Date:  2006-12-12       Impact factor: 3.708

7.  Dimensional assessment of chronic fatigue syndrome.

Authors:  J H Vercoulen; C M Swanink; J F Fennis; J M Galama; J W van der Meer; G Bleijenberg
Journal:  J Psychosom Res       Date:  1994-07       Impact factor: 3.006

8.  Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome.

Authors:  M L Schillings; J S Kalkman; S P van der Werf; B G M van Engelen; G Bleijenberg; M J Zwarts
Journal:  Clin Neurophysiol       Date:  2004-11       Impact factor: 3.708

9.  The development of a model of fatigue in neuromuscular disorders: a longitudinal study.

Authors:  Joke S Kalkman; Maartje L Schillings; Machiel J Zwarts; Baziel G M van Engelen; Gijs Bleijenberg
Journal:  J Psychosom Res       Date:  2007-05       Impact factor: 3.006
  9 in total
  13 in total

1.  Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders.

Authors:  J M Gelauff; E M Kingma; J S Kalkman; R Bezemer; B G M van Engelen; J Stone; M A J Tijssen; J G M Rosmalen
Journal:  J Neurol       Date:  2018-06-02       Impact factor: 4.849

2.  Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.

Authors:  Jin-Sung Park; Namkyun Kim; Donghwi Park
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

3.  Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.

Authors:  Jordi Miró; Kevin J Gertz; Gregory T Carter; Mark P Jensen
Journal:  Muscle Nerve       Date:  2014-06       Impact factor: 3.217

4.  Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom.

Authors:  Esther Brusse; Marjolein G J Brusse-Keizer; Hugo J Duivenvoorden; John C van Swieten
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

5.  Patient-identified disease burden in facioscapulohumeral muscular dystrophy.

Authors:  Nicholas E Johnson; Christine Quinn; Eileen Eastwood; Rabi Tawil; Chad R Heatwole
Journal:  Muscle Nerve       Date:  2012-12       Impact factor: 3.217

6.  Patient identification of the symptomatic impact of charcot-marie-tooth disease type 1A.

Authors:  Nicholas E Johnson; Chad R Heatwole; Michele Ferguson; Janet E Sowden; Shanie Jeanat; David N Herrmann
Journal:  J Clin Neuromuscul Dis       Date:  2013-09

7.  Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy.

Authors:  Amanda E Smith; Kara McMullen; Mark P Jensen; Gregory T Carter; Ivan R Molton
Journal:  Am J Phys Med Rehabil       Date:  2014-05       Impact factor: 2.159

8.  Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: A randomized controlled trial.

Authors:  Landry-Cyrille Bankolé; Guillaume Y Millet; John Temesi; Damien Bachasson; Marion Ravelojaona; Bernard Wuyam; Samuel Verges; Elodie Ponsot; Jean-Christophe Antoine; Fawzi Kadi; Léonard Féasson
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Fatigue and its associated factors in liver transplant recipients in Beijing: a cross-sectional study.

Authors:  Xiao-Hong Lin; Sha Teng; Lu Wang; Jing Zhang; Ya-Bin Shang; Hong-Xia Liu; Yun-Jin Zang
Journal:  BMJ Open       Date:  2017-02-23       Impact factor: 2.692

10.  Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1).

Authors:  Valentina Sancisi; Elena Germinario; Alessandra Esposito; Elisabetta Morini; Samantha Peron; Maurizio Moggio; Giuliano Tomelleri; Daniela Danieli-Betto; Rossella Tupler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-04       Impact factor: 3.619
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.